Nutra Pharma joins bid to raise awarness on AIDS
Florida, USA-headquartered Nutra Pharma, a biotechnology company that is developing drugs for HIV and multiple sclerosis says it has partnered with the European Union-based World AIDS Campaign to help raise awareness about global AIDS initiatives aimed at eradicating the disease by 2015.
"We are pleased to announce our partnership with the World AIDS Campaign," commented Rik Deitsch, chief executive of Nutra Pharma, adding: "this organization serves an important role in the global AIDS community and we are proud to be one of the USA partners."
The World AIDS Campaign was founded in 1997 in Amsterdam, the Netherlands, and is currently managed by the Joint United Nations Program on HIV/AIDS (UNAIDS). The Organization is funded in part by the Ford Foundation, the Soros Foundation, and the Netherlands-based AIDS Fonds.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze